Erste Asset Management’s Axsome Therapeutics AXSM Stock Holding History

Erste Asset Management’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.65M	Hold	11,000	–	–	0.02%	353
2026 Q1	$1.77M	Hold	11,000	–	–	0.02%	379
2025 Q4	$1.66M	Hold	11,000	–	–	0.01%	376
2025 Q3	$1.29M	Hold	11,000	–	–	0.01%	387
2025 Q2	$1.14M	Hold	11,000	–	–	0.01%	485
2025 Q1	$1.3M	Hold	11,000	–	–	0.02%	349
2024 Q4	$954K	Hold	11,000	–	–	0.01%	393
2024 Q3	$986K	Hold	11,000	–	–	0.01%	386
2024 Q2	$881K	Hold	11,000	–	–	0.01%	383
2024 Q1	$871K	Hold	11,000	–	–	0.01%	376
2023 Q4	$876K	Hold	11,000	–	–	0.01%	376
2023 Q3	$804K	Hold	11,000	–	–	0.01%	367
2023 Q2	$804K	Hold	11,000	–	–	0.01%	379
2023 Q1	$666K	Hold	11,000	–	–	0.01%	399
2022 Q4	$842K	Buy	+11,000	New	+$657K	0.02%	377
2022 Q2	–	Sell	-11,000	Closed	-$440K	–	574
2022 Q1	$440K	Hold	11,000	–	–	0.01%	449
2021 Q4	$391K	Buy	+11,000	New	+$405K	0.01%	443
2021 Q1	–	Sell	-11,500	Closed	-$946K	–	501
2020 Q4	$946K	Hold	11,500	–	–	0.03%	342
2020 Q3	$831K	Hold	11,500	–	–	0.03%	314
2020 Q2	$878K	Hold	11,500	–	–	0.04%	301
2020 Q1	$662K	Buy	+11,500	New	+$937K	0.04%	286

Other funds holding AXSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Erste Asset Management's AXSM Position: Q2 2026 in Review

Erste Asset Management held its Axsome Therapeutics (AXSM) position steady in Q2 2026 at 11,000 shares worth $2.65M. The position accounts for 0.02% of the portfolio, ranked #353.

Erste Asset Management first reported a position in AXSM in Q1 2020 and has held it in 21 quarters since. 505 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

Erste Asset Management held 11,000 shares of Axsome Therapeutics worth $2.65M as of Q2 2026.
Erste Asset Management left its Axsome Therapeutics share count unchanged in Q2 2026.
Axsome Therapeutics made up 0.02% of Erste Asset Management's portfolio in Q2 2026, its #353 holding.
Erste Asset Management first reported a position in Axsome Therapeutics in Q1 2020 and has held it in 21 quarters since.
505 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.